Latest Prescription Drugs news
2013 to 2021 Saw Decline in Benzodiazepine Initiation Post-AIS
posted October 17th
by modernClinician Editorial Team
by modernClinician Editorial Team
Substantial Mortality Benefits Expected From Optimal Medication Use for HFrEF
posted October 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Itovebi for Locally Advanced, Metastatic Breast Cancer
posted October 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
Progression-Free Survival Improved With Nivolumab + AVD in Hodgkin Lymphoma
posted October 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL 
Structured Exercise Should Be Considered as Adjunct Therapy for Cancer 
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors .jpg)
Recommendations Updated for Management of Anemia in CKD 
Anifrolumab Tied to Lower Hospitalization, Infection Risk in Lupus 
Therapies Compared for Newly Diagnosed Multiple Sclerosis 
Initial Rx Length Tied to Long-Term Use of Z-Drugs 
Azacitidine + Venetoclax Tied to Improved Event-Free Survival in Adults With AML Monthly Specialist Briefings
Stay Connected
